Table I.
Association between Msi2 expression and patient clinicopathological characteristics.
| Msi2 expression | ||||
|---|---|---|---|---|
| Parameters | n | Low | High | P-value |
| Age, years | 0.452 | |||
| ≤50 | 109 | 50 | 59 | |
| >50 | 53 | 21 | 32 | |
| SCC level, ng/ml | 0.981 | |||
| ≤1.5 | 40 | 15 | 25 | |
| >1.5 | 122 | 46 | 76 | |
| FIGO stage | 0.049a | |||
| ≤I | 125 | 60 | 65 | |
| >I | 37 | 11 | 26 | |
| Tumor size, cm | 0.474 | |||
| ≤4 | 112 | 47 | 65 | |
| >4 | 50 | 24 | 26 | |
| Differentiation | 0.337 | |||
| 1/2 | 64 | 25 | 39 | |
| 3 | 98 | 46 | 53 | |
| Histological type | 0.344 | |||
| SCC | 133 | 56 | 77 | |
| AC | 29 | 15 | 14 | |
| LN Metastasis | 0.004a | |||
| No | 132 | 62 | 70 | |
| Yes | 30 | 9 | 21 | |
P<0.05; Msi2, Musashi-2; SCC, squamous cell cancer; FIGO, International Federation of Gynecology and Obstetrics; AC, adenocarcinoma; LN, lymph node; y, years.